Desk› Healthcare› GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Filing rhythm · 60 trading days
27 filings · 6 material · busiest 2026-08-03
What it files
Filings
27 in the window
-
19 August 2026
-
14 August 2026
Newspaper PublicationNewspaper Publication
As per attachment
Company Update / Newspaper Publication View filing →
-
13 August 2026
Postal BallotShareholder Meeting / Postal Ballot-Notice of Postal Ballot
As per attachment
AGM/EGM / Postal Ballot View filing →
-
6 August 2026
GeneralDisclosure Under Regulation 30
IT Refund of Rs 52 crores
Company Update / General View filing →
-
6 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Transcript
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
As per attachment
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026
Newspaper PublicationNewspaper Publication
As per attachment
Company Update / Newspaper Publication View filing →
-
3 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Meeting
Outcome of Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026
ResultsResults For Quarter 30Th June 2026
Outcome of meeting
Result / Financial Results View filing →
-
3 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Presentation
Company Update / Analyst / Investor Meet View filing →
-
3 August 2026
Press ReleasePress Release / Media Release
As per attachment
Company Update / Press Release / Media Release View filing →
-
3 August 2026
Change in DirectorateChange in Directorate
As per attachment
Company Update / Change in Directorate View filing →
-
3 August 2026
ResignationResignation of Director
As per attachment
Company Update / Resignation of Director View filing →
-
3 August 2026
Change in ManagementChange in Management
Reappointment of Managing Director
Company Update / Change in Management View filing →
-
3 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
As per attachment
Company Update / Analyst / Investor Meet View filing →
-
21 July 2026
Board MeetingBoard Meeting Intimation for Approve And Take On Record The Un-Audited Financial Results For The First Quarter Ended 30Th June 2026.
Glaxosmithkline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and ....
Board Meeting / Board Meeting View filing →
-
21 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
As per attachment
Company Update / Analyst / Investor Meet View filing →
-
8 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 June 2026
AGM / EGMShareholder Meeting / Postal Ballot-Outcome of AGM
As per attachment
AGM/EGM / AGM View filing →
-
30 June 2026
AGM / EGMShareholder Meeting / Postal Ballot-Scrutinizer's Report
As per attachment
AGM/EGM / AGM View filing →
-
26 June 2026
Trading WindowClosure of Trading Window
As per attachment
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 June 2026
-
9 June 2026
Newspaper PublicationNewspaper Publication
As per attachment
Company Update / Newspaper Publication View filing →
-
8 June 2026
GeneralLetter For Website Link For Annual Report
As per attachment
Company Update / General View filing →
-
5 June 2026
Annual ReportReg. 34 (1) Annual Report.
Annual Report for 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
5 June 2026
BRSRBusiness Responsibility and Sustainability Reporting (BRSR)
BRSR Report for 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
5 June 2026